Use of Cervista HPV HR assay for detection of human papillomavirus in samples with hybrid capture borderline negative results.
APMIS
; 118(9): 681-4, 2010 Sep 01.
Article
em En
| MEDLINE
| ID: mdl-20718720
ABSTRACT
We have evaluated Cervista HPV HR for papillomavirus detection in 65 samples previously borderline negative by the hybrid capture method (Digene), using InnoLipa and sequencing as confirmatory techniques. Nine samples were found to be positive by Cervista HPV HR, of which five (7.6%) were confirmed by InnoLipa. Four samples (6.1%) were false positive, of which three samples were reactive for A9 probes. The Cervista HPV HR assay can detect HPV-positive samples from those with hybrid capture borderline results but can produce false-positive results when tested for reactivity with A9 probes.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Alphapapillomavirus
Tipo de estudo:
Diagnostic_studies
Limite:
Aged
/
Animals
/
Female
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article